AMPH vs. NVO
Compare and contrast key facts about Amphastar Pharmaceuticals, Inc. (AMPH) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMPH or NVO.
Key characteristics
| AMPH | NVO | |
|---|---|---|
| YTD Return | -31.35% | 19.56% |
| 1Y Return | 16.14% | 54.71% |
| 3Y Return (Ann) | 32.85% | 50.76% |
| 5Y Return (Ann) | 13.71% | 40.72% |
| Sharpe Ratio | 0.37 | 1.48 |
| Daily Std Dev | 45.74% | 32.49% |
| Max Drawdown | -49.92% | -71.28% |
| Current Drawdown | -34.68% | -9.00% |
Fundamentals
| AMPH | NVO | |
|---|---|---|
| Market Cap | $2.07B | $548.93B |
| EPS | $2.60 | $2.87 |
| PE Ratio | 16.33 | 42.87 |
| PEG Ratio | 2.77 | 2.40 |
| Revenue (TTM) | $644.40M | $244.24B |
| Gross Profit (TTM) | $248.86M | $148.51B |
| EBITDA (TTM) | $237.72M | $117.85B |
Correlation
The correlation between AMPH and NVO is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
AMPH vs. NVO - Performance Comparison
In the year-to-date period, AMPH achieves a -31.35% return, which is significantly lower than NVO's 19.56% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
AMPH vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AMPH vs. NVO - Dividend Comparison
AMPH has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 0.67%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AMPH Amphastar Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 0.67% | 0.36% | 0.42% | 0.47% | 0.67% | 0.76% | 0.98% | 0.76% | 1.44% | 0.46% | 0.72% | 0.12% |
Drawdowns
AMPH vs. NVO - Drawdown Comparison
The maximum AMPH drawdown since its inception was -49.92%, smaller than the maximum NVO drawdown of -71.28%. Use the drawdown chart below to compare losses from any high point for AMPH and NVO. For additional features, visit the drawdowns tool.
Volatility
AMPH vs. NVO - Volatility Comparison
Amphastar Pharmaceuticals, Inc. (AMPH) has a higher volatility of 8.30% compared to Novo Nordisk A/S (NVO) at 7.03%. This indicates that AMPH's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AMPH vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities